US WorldMeds, LLC and Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, have entered into an exclusive agreement to co-promote US WorldMeds’ Lucemyra (lofexidine). The FDA approved Lucemyra on May 16, 2018 as the first and only non-opioid medication for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. Opioid withdrawal is an…